Quinoline derivatives as phosphodiesterase inhibitors

There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	REDGRAVE ALISON JUDITH, HOLMAN STUART, EVANS BRIAN, ELDRED COLIN DAVID, LINDVALL MIKA KRISTIAN, LUNNISS CHRISTOPHER JAMES, HAMBLIN JULIE NICOLE, BALDWIN IAN ROBERT, ROBINSON JOHN EDWARD, GUNTRIP STEPHEN BARRY, JONES PAUL, REDFERN TRACY JANE, GOUGH SHARON LISA, WOODROW MICHAEL, DEAN ANTHONY WILLIAM, BARKER MICHAEL DAVID
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.